Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2020

18.10.2019 | Epidemiology

Body mass index and risk of breast cancer molecular subtypes in Korean women: a case–control study

verfasst von: Seok Hun Jeong, Yoonsuk An, Choonghyun Ahn, Boyoung Park, Min Hyuk Lee, Dong-Young Noh, Sue K. Park

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Our main objective of this research was to analyze the effect of BMI on breast cancer risk according to various subtypes of breast cancer stratified with menopausal status.

Methods

By using a case–control study setting, we recruited a total of 16,190 female breast cancer patients aged between 35 and 80 years from 2003 to 2010. These breast cancer patients were then individually matched by age to control female group (1:2 ratios of cases and controls). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated via multivariable logistic regression by setting normal BMI range (18.5–22.9) as the reference group.

Results

In premenopausal women, the risk of breast cancer of triple-negative subtype increased (OR 1.60, 95% CI 1.27–2.02) in obese II (BMI ≥ 30) women and in underweight women, it was Luminal A (OR 1.24, 95% CI 1.06–1.45) and HER2 express subtype (OR 1.43, 95% CI 1.26–1.62) that showed increased risk of breast cancer. In postmenopausal women, Luminal A (OR 2.35, 95% CI 2.01–2.75), Luminal B HER2 negative (OR 1.81, 95% CI 1.46–2.25) and triple-negative subtype (OR 2.25, 95% CI 1.85–2.72) showed higher risk of breast cancer in obese II women.

Conclusion

Our findings suggest that the effect of BMI on breast cancer differs according to various subtypes and hormone receptors and to menopausal status.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30CrossRef Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30CrossRef
2.
Zurück zum Zitat Jung K-W, Won Y-J, Oh C-M, Kong H-J, Lee DH, Lee KH (2017) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat 49(2):292CrossRef Jung K-W, Won Y-J, Oh C-M, Kong H-J, Lee DH, Lee KH (2017) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat 49(2):292CrossRef
3.
Zurück zum Zitat Park EH, Min SY, Kim Z, Yoon CS, Jung K-W, Nam SJ, Oh SJ, Lee S, Park B-W, Lim W (2017) Basic facts of breast cancer in Korea in 2014: the 10-year overall survival progress. J Breast Cancer 20(1):1–11CrossRef Park EH, Min SY, Kim Z, Yoon CS, Jung K-W, Nam SJ, Oh SJ, Lee S, Park B-W, Lim W (2017) Basic facts of breast cancer in Korea in 2014: the 10-year overall survival progress. J Breast Cancer 20(1):1–11CrossRef
4.
Zurück zum Zitat Kawai M, Minami Y, Kuriyama S, Kakizaki M, Kakugawa Y, Nishino Y, Ishida T, Fukao A, Tsuji I, Ohuchi N (2010) Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study. Br J Cancer 103(9):1443–1447CrossRef Kawai M, Minami Y, Kuriyama S, Kakizaki M, Kakugawa Y, Nishino Y, Ishida T, Fukao A, Tsuji I, Ohuchi N (2010) Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study. Br J Cancer 103(9):1443–1447CrossRef
5.
Zurück zum Zitat Sweeney C, Blair CK, Anderson KE, Lazovich D, Folsom AR (2004) Risk factors for breast cancer in elderly women. Am J Epidemiol 160(9):868–875CrossRef Sweeney C, Blair CK, Anderson KE, Lazovich D, Folsom AR (2004) Risk factors for breast cancer in elderly women. Am J Epidemiol 160(9):868–875CrossRef
6.
Zurück zum Zitat Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE (2009) Breast cancer risk factors defined by estrogen and progesterone receptor status the multiethnic cohort study. Am J Epidemiol 169:1251–1259CrossRef Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE (2009) Breast cancer risk factors defined by estrogen and progesterone receptor status the multiethnic cohort study. Am J Epidemiol 169:1251–1259CrossRef
7.
Zurück zum Zitat Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, Hainaut P (2013) Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev 14(8):665–678CrossRef Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, Hainaut P (2013) Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev 14(8):665–678CrossRef
8.
Zurück zum Zitat Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, Wang DY (1997) Re: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 89(5):396–397CrossRef Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, Wang DY (1997) Re: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 89(5):396–397CrossRef
9.
Zurück zum Zitat Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC (1985) Do regular ovulatory cycles increase breast cancer risk? Cancer 56(5):1206–1208CrossRef Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC (1985) Do regular ovulatory cycles increase breast cancer risk? Cancer 56(5):1206–1208CrossRef
10.
Zurück zum Zitat Millikan RC, Newman B, Tse C-K, Moorman PG, Conway K, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123–139CrossRef Millikan RC, Newman B, Tse C-K, Moorman PG, Conway K, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123–139CrossRef
11.
Zurück zum Zitat Li H, Sun X, Miller E, Wang Q, Tao P, Liu L, Zhao Y, Wang M, Qi Y, Li J (2017) BMI, reproductive factors, and breast cancer molecular subtypes: a case-control study and meta-analysis. J Epidemiol 27(4):143–151CrossRef Li H, Sun X, Miller E, Wang Q, Tao P, Liu L, Zhao Y, Wang M, Qi Y, Li J (2017) BMI, reproductive factors, and breast cancer molecular subtypes: a case-control study and meta-analysis. J Epidemiol 27(4):143–151CrossRef
12.
Zurück zum Zitat Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Anderson WF, Szeszenia-Dąbrowska N, Bardin-Mikolajczak A (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Prev Biomark 16(3):439–443CrossRef Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Anderson WF, Szeszenia-Dąbrowska N, Bardin-Mikolajczak A (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Prev Biomark 16(3):439–443CrossRef
13.
Zurück zum Zitat Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko S-S, Han W (2007) Poor outcome of hormone receptor–positive breast cancer at very young age is due to Tamoxifen resistance: nationwide survival data in Korea—a report from the Korean Breast Cancer Society. J Clin Oncol 25(17):2360–2368CrossRef Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko S-S, Han W (2007) Poor outcome of hormone receptor–positive breast cancer at very young age is due to Tamoxifen resistance: nationwide survival data in Korea—a report from the Korean Breast Cancer Society. J Clin Oncol 25(17):2360–2368CrossRef
14.
Zurück zum Zitat Kim Y, Han B-G (2016) Cohort profile: the Korean genome and epidemiology study (KoGES) Consortium. Int Epidemiol 46(2):e20CrossRef Kim Y, Han B-G (2016) Cohort profile: the Korean genome and epidemiology study (KoGES) Consortium. Int Epidemiol 46(2):e20CrossRef
15.
Zurück zum Zitat Organization WH (2000) The Asia-Pacific perspective: redefining obesity and its treatment. In: Sydney: Health Communications Australia Organization WH (2000) The Asia-Pacific perspective: redefining obesity and its treatment. In: Sydney: Health Communications Australia
16.
Zurück zum Zitat Goldhirsch A, Wood W, Coates A, Gelber R, Thürlimann B, Senn H-J (2011) Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22(8):1736–1747CrossRef Goldhirsch A, Wood W, Coates A, Gelber R, Thürlimann B, Senn H-J (2011) Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22(8):1736–1747CrossRef
17.
Zurück zum Zitat Goldhirsch A, Winer EP, Coates A, Gelber R, Piccart-Gebhart M, Thürlimann B, Senn H-J, Albain KS, André F (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24(9):2206–2223CrossRef Goldhirsch A, Winer EP, Coates A, Gelber R, Piccart-Gebhart M, Thürlimann B, Senn H-J, Albain KS, André F (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24(9):2206–2223CrossRef
18.
Zurück zum Zitat Stekhoven DJ, Bühlmann P (2011) MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics 28(1):112–118CrossRef Stekhoven DJ, Bühlmann P (2011) MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics 28(1):112–118CrossRef
19.
Zurück zum Zitat Millikan RC, Newman B, Tse C-K, Moorman PG, Conway K, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123–139CrossRef Millikan RC, Newman B, Tse C-K, Moorman PG, Conway K, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109(1):123–139CrossRef
20.
Zurück zum Zitat Cleary MP, Maihle NJ (1997) The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 216(1):28–43CrossRef Cleary MP, Maihle NJ (1997) The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 216(1):28–43CrossRef
21.
Zurück zum Zitat Rose DP, Vona-Davis L (2010) Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 66(1):33–38CrossRef Rose DP, Vona-Davis L (2010) Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 66(1):33–38CrossRef
22.
Zurück zum Zitat Van Mieghem T, Leunen K, Pochet N, De Moor B, De Smet F, Amant F, Berteloot P, Timmerman D, Bempt IV, Drijkoningen R (2007) Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age. Breast Cancer Res Treat 106(1):127–133CrossRef Van Mieghem T, Leunen K, Pochet N, De Moor B, De Smet F, Amant F, Berteloot P, Timmerman D, Bempt IV, Drijkoningen R (2007) Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age. Breast Cancer Res Treat 106(1):127–133CrossRef
23.
Zurück zum Zitat Laidlaw I, Clarke RB, Howell A, Owen A, Potten CS, Anderson E (1995) The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 136(1):164–171CrossRef Laidlaw I, Clarke RB, Howell A, Owen A, Potten CS, Anderson E (1995) The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 136(1):164–171CrossRef
24.
Zurück zum Zitat Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578CrossRef Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578CrossRef
25.
Zurück zum Zitat Korea statistics agency (kostat.go.kr) Korea statistics agency (kostat.go.kr)
26.
Zurück zum Zitat Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578CrossRef Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578CrossRef
27.
Zurück zum Zitat Wolff AC, Hammond MEH, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A (2006) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118–145CrossRef Wolff AC, Hammond MEH, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A (2006) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118–145CrossRef
Metadaten
Titel
Body mass index and risk of breast cancer molecular subtypes in Korean women: a case–control study
verfasst von
Seok Hun Jeong
Yoonsuk An
Choonghyun Ahn
Boyoung Park
Min Hyuk Lee
Dong-Young Noh
Sue K. Park
Publikationsdatum
18.10.2019
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05451-1

Weitere Artikel der Ausgabe 2/2020

Breast Cancer Research and Treatment 2/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.